Patents by Inventor Achim Schneeberger

Achim Schneeberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug delivery system
    Patent number: 11986558
    Abstract: The present invention relates to a drug delivery system, in particular for a controlled administration of one or more active pharmaceutical ingredients to a body, and further in particular for oral administration of one or more active pharmaceutical ingredients to a body. The system thereby comprises a base component soluble in body fluids and a separate first component soluble in body fluids. The first component thereby comprises a therapeutically effective amount of a first active pharmaceutical ingredient.
    Type: Grant
    Filed: July 13, 2022
    Date of Patent: May 21, 2024
    Assignees: Laxxon Medical AG, Exentis Knowledge GmbH
    Inventors: Achim Schneeberger, Klaus Kühne, Helmut Kerschbaumer, Srdan Vasic
  • TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE (AD)
    Publication number: 20240148782
    Abstract: The invention discloses an aluminium salt for use in the treatment and prevention of dementias associated with ?-amyloid deposition, preferably AD.
    Type: Application
    Filed: November 20, 2023
    Publication date: May 9, 2024
    Inventors: Markus Mandler, Achim Schneeberger, Wolfgang Zauner, Arne Von Bonin, Frank Mattner, Walter Schmidt
  • Treatment and prevention of Alzheimer's disease (AD)
    Patent number: 11857568
    Abstract: The invention discloses an aluminium salt for use in the treatment and prevention of dementias associated with ?-amyloid deposition, preferably AD.
    Type: Grant
    Filed: July 8, 2021
    Date of Patent: January 2, 2024
    Assignee: Advantage Therapeutics, Inc.
    Inventors: Markus Mandler, Achim Schneeberger, Wolfgang Zauner, Arne Von Bonin, Frank Mattner, Walter Schmidt
  • METHOD FOR PRODUCING A DRUG DELIVERY SYSTEM
    Publication number: 20230078273
    Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.
    Type: Application
    Filed: August 15, 2022
    Publication date: March 16, 2023
    Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
  • METHOD FOR PRODUCING A DRUG DELIVERY SYSTEM
    Publication number: 20230008781
    Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.
    Type: Application
    Filed: August 15, 2022
    Publication date: January 12, 2023
    Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
  • METHOD FOR PRODUCING A DRUG DELIVERY SYSTEM
    Publication number: 20220387331
    Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.
    Type: Application
    Filed: August 15, 2022
    Publication date: December 8, 2022
    Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
  • METHOD FOR PRODUCING A DRUG DELIVERY SYSTEM
    Publication number: 20220387332
    Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.
    Type: Application
    Filed: August 15, 2022
    Publication date: December 8, 2022
    Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
  • METHOD FOR PRODUCING A DRUG DELIVERY SYSTEM
    Publication number: 20220387330
    Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.
    Type: Application
    Filed: August 15, 2022
    Publication date: December 8, 2022
    Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
  • Method for producing a drug delivery system
    Patent number: 11484504
    Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: November 1, 2022
    Assignees: Laxxon Medical AG, Exentis Knowledge GmbH
    Inventors: Achim Schneeberger, Klaus Kühne, Helmut Kerschbaumer, Srdan Vasic
  • DRUG DELIVERY SYSTEM
    Publication number: 20220339109
    Abstract: The present invention relates to a drug delivery system, in particular for a controlled administration of one or more active pharmaceutical ingredients to a body, and further in particular for oral administration of one or more active pharmaceutical ingredients to a body. The system thereby comprises a base component soluble in body fluids and a separate first component soluble in body fluids. The first component thereby comprises a therapeutically effective amount of a first active pharmaceutical ingredient.
    Type: Application
    Filed: July 13, 2022
    Publication date: October 27, 2022
    Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
  • TABLET HAVING A TWO-DIMENSIONAL IDENTIFIER
    Publication number: 20220304895
    Abstract: A solid dosage form for active ingredient release can be a preparation for medical, dental or cosmetic purposes, and is preferably a tablet. The solid dosage form comprises a three-dimensional base body which comprises an active ingredient. The solid dosage form further comprises a portion having a structure forming a two-dimensional identifier, such as, for instance, a QR code.
    Type: Application
    Filed: March 23, 2022
    Publication date: September 29, 2022
    Inventors: Klaus KÜHNE, Helmut KERSCHBAUMER, Daniel MOLDENHAUER, Alexander RUCKDÄSCHEL, Achim SCHNEEBERGER
  • Drug delivery system
    Patent number: 11419824
    Abstract: The present invention relates to a drug delivery system, in particular for a controlled administration of one or more active pharmaceutical ingredients to a body, and further in particular for oral administration of one or more active pharmaceutical ingredients to a body. The system thereby comprises a base component soluble in body fluids and a separate first component soluble in body fluids. The first component thereby comprises a therapeutically effective amount of a first active pharmaceutical ingredient.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: August 23, 2022
    Assignees: Laxxon Medical AG, Exentis Knowledge GmbH
    Inventors: Achim Schneeberger, Klaus Kühne, Helmut Kerschbaumer, Srdan Vasic
  • TREATMENT OF ALZHEIMER'S DISEASE (AD) WITH AN ALUMINUM SALT
    Publication number: 20220062412
    Abstract: Disclosed is a method for the treatment of AD, wherein an immune stimulating pharmaceutical composition comprising an aluminium salt is administered to a patient having AD or having a risk to develop AD in an effective amount.
    Type: Application
    Filed: September 23, 2021
    Publication date: March 3, 2022
    Inventors: Markus Mandler, Achim Schneeberger, Frank Mattner, Walter Schmidt
  • TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE (AD)
    Publication number: 20220000908
    Abstract: The invention discloses an aluminium salt for use in the treatment and prevention of dementias associated with ?-amyloid deposition, preferably AD.
    Type: Application
    Filed: July 8, 2021
    Publication date: January 6, 2022
    Inventors: Markus Mandler, Achim Schneeberger, Wolfgang Zauner, Arne Von Bonin, Frank Mattner, Walter Schmidt
  • Treatment of Alzheimer's Disease (AD) with an aluminum salt
    Patent number: 11147873
    Abstract: Disclosed is a method for the treatment of AD, wherein an immune stimulating pharmaceutical composition comprising an aluminium salt is administered to a patient having AD or having a risk to develop AD in an effective amount.
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: October 19, 2021
    Assignee: Advantage Therapeutics, Inc.
    Inventors: Markus Mandler, Achim Schneeberger, Frank Mattner, Walter Schmidt
  • Treatment and prevention of alzheimer's disease (AD)
    Patent number: 11065273
    Abstract: The invention discloses an aluminium salt for use in the treatment and prevention of dementias associated with ?-amyloid deposition, preferably AD.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: July 20, 2021
    Assignee: AFFIRIS AG
    Inventors: Markus Mandler, Achim Schneeberger, Wolfgang Zauner, Arne Von Bonin, Frank Mattner, Walter Schmidt
  • METHOD FOR PRODUCING A DRUG DELIVERY SYSTEM
    Publication number: 20200390714
    Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.
    Type: Application
    Filed: December 29, 2017
    Publication date: December 17, 2020
    Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
  • Treatment of Local Skin Hypotrophy Conditions
    Publication number: 20200369738
    Abstract: The invention discloses Fibroblast growth factor 2 (FGF2) and Fibroblast growth factor 7 (FGF7) messenger-RNA (mRNA), wherein the mRNA has a 5? CAP region, a 5? untranslated region (5?-UTR), a coding region, a 3? untranslated region (3?-UTR) and a poly-adenosine tail (poly-A tail), for use in the treatment of local skin hypotrophy conditions and kits for administrating this mRNA to a human patient in need thereof.
    Type: Application
    Filed: July 31, 2018
    Publication date: November 26, 2020
    Inventors: Markus MANDLER, Frank MATTNER, Walter SCHMIDT, Achim SCHNEEBERGER
  • TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE (AD)
    Publication number: 20200338192
    Abstract: Disclosed is a method for the treatment of AD, wherein an immune stimulating pharmaceutical composition comprising an aluminium salt is administered to a patient having AD or having a risk to develop AD in an effective amount.
    Type: Application
    Filed: March 17, 2020
    Publication date: October 29, 2020
    Applicant: AFFIRIS AG
    Inventors: Markus MANDLER, Achim SCHNEEBERGER, Frank MATTNER, Walter SCHMIDT
  • DRUG DELIVERY SYSTEM
    Publication number: 20200330390
    Abstract: The present invention relates to a drug delivery system, in particular for a controlled administration of one or more active pharmaceutical ingredients to a body, and further in particular for oral administration of one or more active pharmaceutical ingredients to a body. The system thereby comprises a base component soluble in body fluids and a separate first component soluble in body fluids. The first component thereby comprises a therapeutically effective amount of a first active pharmaceutical ingredient.
    Type: Application
    Filed: December 29, 2017
    Publication date: October 22, 2020
    Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC